How Ibrutinib Has Transformed the Treatment Paradigm of CLL

Video

Javier Pinilla-Ibarz, MD, PhD, associate member, Malignant Hematology and Immunology Program at the H. Lee Moffitt Cancer Center, discusses how ibrutinib has transformed the treatment landscape of chronic lymphocytic leukemia.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content